Linyantong (Wuxi) Technology Co., Ltd. has officially changed its name to Linyantong Medical Research (Wuxi) Co., Ltd. This renaming marks a significant milestone in the company's development, reflecting its strategic focus and service upgrade in the field of medical research.

The rebranding aims to more accurately convey its core business positioning—dedicated to medical research and empowering scientific innovation—while enhancing the brand's recognition and influence in this field. It also clarifies its strategic role as the core pillar of the group's medical research sector, enabling better collaborative development and responding to the industry's demand for specialized and segmented services.

Following the name change, the core team, business scope (covering full-cycle clinical research support, including CRO services, data management, institutional filing, etc.), and commitment to partnerships (adhering to integrity, innovation, and win-win principles) remain unchanged.

Under the new name, the team has expanded, bringing together multidisciplinary professionals; service quality has been upgraded with optimized processes and advanced management and quality control systems; and the research fields have broadened to include clinical medicine, basic medicine, preventive medicine, and more.

The company will seize this rebranding opportunity to continuously enhance its technical capabilities and optimize its service system, striving to become a trusted partner in the medical research field and jointly promote the development of the healthcare industry with all sectors.